Impaired cardiac glycolysis and glycogen depletion are linked to poor myocardial outcomes in juvenile male swine with metabolic syndrome and ischemia

Mark Broadwin, Dwight D. Harris, Sharif A. Sabe, Elif Sengun, Amber J. Sylvestre, Boian S. Alexandrov, Frank W. Sellke, Anny UshevaPhysiological 2023 · DOI

TL;DR

This study reveals that metabolic syndrome (MetS) in juvenile swine, induced by an obesogenic diet, significantly impairs cardiac glycolysis and glycogen stores, leading to reduced ATP availability and potentially contributing to poor myocardial outcomes during ischemia. These findings highlight a critical window of metabolic vulnerability in the developing heart under MetS conditions, suggesting new therapeutic targets.

What Problem Does This Paper Address?

Childhood obesity is on the rise, leading to an increased prevalence of metabolic syndrome (MetS) in young individuals. MetS is a known risk factor for cardiovascular disease, but the precise mechanisms by which it impacts the juvenile heart, especially in conjunction with ischemic events, remain poorly understood. Existing research often relies on correlations or animal models that don't fully capture human physiology. This paper aims to elucidate the specific metabolic alterations in the juvenile myocardium under MetS conditions and chronic ischemia, bridging a critical knowledge gap in understanding early-onset cardiovascular risk.

Methods

The researchers employed a multi-omics approach in a juvenile swine model.

  • Metabolic Syndrome Induction: Male Ossabaw swine were fed either a high-fat, obesogenic diet (OD) or a control lean diet (LD) for 11 weeks.
  • Myocardial Ischemia: Chronic ischemia was induced by surgically placing an ameroid constrictor on the left circumflex artery at 15 weeks of age.
  • Tissue Analysis: At 22 weeks, myocardial tissue was harvested and subjected to:
  • Targeted Liquid Chromatography-Tandem Mass Spectrometry (LC/MS-MS): To quantify polar metabolites, focusing on glycolysis-related pathways.
  • RNA-Sequencing (RNA-seq): To analyze gene expression profiles.
  • Proteomics (LC/MS-MS): To quantify protein levels.
  • Data Integration and Analysis:
    • Nonnegative Matrix Factorization (NMF): Used as an unsupervised learning method to identify metabolic signatures and compare variations between MetS and LD groups, especially given the limited number of replicates.
  • g:Profiler: Employed for pathway-related and biological process analyses of RNA-seq data.
  • Statistical Analysis: Unpaired two-tailed Student's t-tests were used for comparisons, with a significance threshold of p<0.05.
  • Glycogen Content: Assessed using Periodic acid Schiff (PAS) staining.
  • Western Blotting: Used to validate protein expression levels for specific enzymes.

Datasets

  • Swine Myocardial Tissue: Samples from juvenile male Ossabaw swine (n=6 per group: MetS and LD) were used for metabolomics, proteomics, and RNA-seq.
  • Swine Blood Samples: Collected for comparative metabolite analysis.
  • NCBI Sus scrofa Database: Used for peptide spectrum matching in proteomics.

No new benchmarks were introduced; the study focused on analyzing existing data types using established and novel analytical approaches (like NMF for integration).

Key Insights and Ideas

  • Metabolic Vulnerability in Juvenile Hearts: The study highlights that juvenile hearts are not immune to the metabolic derangements of MetS and ischemia, showing significant impairments in energy substrate utilization.
  • Glycolysis as a Key Target: The findings strongly implicate impaired glycolysis as a central issue in MetS-affected juvenile hearts, with reduced levels of key glycolytic intermediates and enzymes.
  • Glycogen Depletion Mechanism: The observed severe depletion of myocardial glycogen in MetS is linked to an imbalance between glycogen synthesis (GYS1 downregulation) and glycogen breakdown (PYGM/PYGL upregulation), suggesting a dysregulated control mechanism.
  • NMF for Multi-Omics Integration: The use of NMF proved effective in integrating diverse omics data (metabolomics, transcriptomics, proteomics) to identify overarching metabolic signatures, especially useful with limited sample sizes.
  • Potential for Therapeutic Intervention: The identification of specific metabolic pathways and enzymes that are dysregulated provides clear targets for future pharmacological interventions aimed at improving cardiac function in MetS.

Key Results

  • MetS Phenotype: Swine on the obesogenic diet exhibited classic MetS criteria: hyperglycemia, elevated triglycerides, increased LDL, increased total cholesterol, weight gain, and higher blood pressure.
  • Glycolytic Metabolite Reduction: In MetS hearts, there was a significant decrease in glucose-6-phosphate (G6P), fructose-6-phosphate (F6P), fructose-1,6-bisphosphate (FBP), and pyruvate, key intermediates in glycolysis. ATP levels were also reduced.
  • Enzyme Dysregulation: Protein levels of glucose transporters (GLUT1, GLUT4) and mitochondrial hexokinase 1 (HK1) were significantly lower in MetS hearts, impairing glucose uptake and initial metabolism. Glucose-6-phosphate isomerase (PGI) and phosphofructokinase (PFKM) also showed reduced protein levels.
  • Glycogen Deficiency: PAS staining revealed significantly less glycogen in MetS hearts. This was associated with reduced expression of glycogen synthase 1 (GYS1) and increased expression of glycogen phosphorylases (PYGM/PYGL).
  • ATP Depletion: The combined effects of impaired glycolysis and glycogenolysis lead to diminished ATP availability in the myocardium.

Limitations and Future Work

  • Gender Differences: The study did not investigate potential gender-specific responses to MetS and oxygen deprivation. Future work could explore these differences using the multi-omics approach.
  • Animal Model: While a large animal model is advantageous, the expense limits the number of animals that can be studied, impacting statistical power. Additionally, morphometric functional data (e.g., echocardiography) could not be obtained.
  • Mechanistic Details: While the study identifies dysregulated pathways, the precise flux of myocardial pyruvate and the detailed mechanisms of FBP's protective effects require further investigation.
  • Therapeutic Targets: The identified metabolic alterations, particularly the imbalance in glycogen metabolism and the reduced glycolytic flux, represent promising targets for pharmacological agents to improve juvenile myocardial function in MetS and ischemia.

Summary updated

Abstract

Obesity continues to rise in the juveniles and obese children are more likely to develop metabolic syndrome (MetS) and related cardiovascular disease. Unfortunately, effective prevention and long-term treatment options remain limited. We determined the juvenile cardiac response to MetS in a swine model. Juvenile male swine were fed either an obesogenic diet, to induce MetS, or a lean diet, as a control (LD). Myocardial ischemia was induced with surgically placed ameroid constrictor on the left circumflex artery. Physiological data were recorded and at 22 weeks of age the animals underwent a terminal harvest procedure and myocardial tissue was extracted for total metabolic and proteomic LC/MS-MS, RNA-seq analysis, and data underwent nonnegative matrix factorization for metabolic signatures. Significantly altered in MetS versus. LD were the glycolysis-related metabolites and enzymes. In MetS compared with LD Glycogen synthase 1 (GYS1)-glycogen phosphorylases (PYGM/PYGL) expression disbalance resulted in a loss of myocardial glycogen. Our findings are consistent with the concept that transcriptionally driven myocardial changes in glycogen and glucose metabolism-related enzymes lead to a deficiency of their metabolite products in MetS. This abnormal energy metabolism provides insight into the pathogenesis of the juvenile heart in MetS. This study reveals that MetS and ischemia diminishes ATP availability in the myocardium via altering the glucose-G6P-pyruvate axis at the level of metabolites and gene expression of related enzymes. The observed severe glycogen depletion in MetS coincides with disbalance in expression of GYS1 and both PYGM and PYGL. This altered energy substrate metabolism is a potential target of pharmacological agents for improving juvenile myocardial function in MetS and ischemia.
BibTeX
@inproceedings{broadwin2023impaired,
  author = {Mark Broadwin and Dwight D. Harris and Sharif A. Sabe and Elif Sengun and Amber J. Sylvestre and Boian S. Alexandrov and Frank W. Sellke and Anny Usheva},
  title = {{Impaired cardiac glycolysis and glycogen depletion are linked to poor myocardial outcomes in juvenile male swine with metabolic syndrome and ischemia}},
  booktitle = {Physiological},
  year = {2023},
  doi = {10.14814/phy2.15742},
}
Figure